Common Biological Pathways Underlying the Psychoneurological Symptom Cluster in Cancer Patients
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
BACKGROUND: A symptom cluster is a group of symptoms that occur together and are interrelated. The clinical implication of symptom cluster research is to use the clustering patterns of symptoms to understand the mechanisms for these symptoms and develop management strategies targeted at multiple symptoms. OBJECTIVE: The purposes of this review were to summarize the evidence for a psychoneurological symptom cluster in cancer patients, to provide information regarding the underlying biological mechanisms for each of the psychoneurological symptoms within the cluster, and to propose possible common biological pathways that may underlie this cluster. METHODS: A systematic review of the literature was conducted. RESULTS: Empirical evidence exists to support a cluster of psychoneurological symptoms (ie, depressive symptoms, cognitive disturbance, fatigue, sleep disturbance, pain). At a molecular level, common biological pathways (ie, proinflammatory cytokines, hypothalamic-pituitary-adrenal axis, and monoamine neurotransmission system) may underlie the development of symptoms within this cluster. Activation of proinflammatory cytokines is proposed as a first stage of mechanistic pathway. However, other biological factors, such as lowered estrogen or hemoglobin levels, may influence psychoneurological cluster. CONCLUSION: Additional studies are needed to confirm the roles of cytokines as well as other biological factors in the development of the psychoneurological cluster and to determine the biomarkers to identify the subgroups of cancer patients who are at greatest risk for this cluster. IMPLICATIONS FOR PRACTICE: This information can be used by researchers and clinicians to guide the selection of symptom management strategies that are ideally targeted to the biological mechanisms that underlie this symptom cluster.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848 · cited 1×
“However, researchers generally agree that cytokines can induce depressive symptoms at least in a subset of patients, particularly those who are medically ill.(62) The majority of the evidence for all of the proposed mechanisms comes from studies of major depression in healthy persons or those with other chronic illnes…”
BackgroundHypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress
Tsigos, C., & Chrousos, G. P. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(02)00429-4 · Cited by 2,822
Cytokines and major depression
Schiepers, O. J. G., Wichers, M. C., & Maes, M. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.11.003 · Cited by 1,235 · cited 3×
“Therefore, longitudinal studies are needed that correlate symptoms of sickness behavior in humans with acute and chronic changes in cytokine levels that are induced by cancer and its treatment.(3,57)”
BackgroundKawasaki, Y., Zhang, L., Cheng, J.-K., & Ji, R.-R. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3338-07.2008 · Cited by 1,162 · cited 1×
“substance P and neurokinin A,(159) prostaglandins,(164) and proinflammatory cytokines.(165,166) Findings from animal studies suggest that cancer can cause peripheral and central sensitization.”
BackgroundFatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life.
Bower, J. E., Ganz, P. A., Desmond, K. A., Rowland, J. H., Meyerowitz, B. E., & Belin, T. R. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.4.743 · Cited by 1,134
Role of the Immune system in chronic pain
Marchand, F., Perretti, M., & McMahon, S. B. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1700 · Cited by 1,098
Vgontzas, A. N., Papanicolaou, D. A., Bixler, E. O., Kales, A., Tyson, K., & Chrousos, G. P. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.5.3950 · Cited by 974 · cited 1×
“…and 5:00 AM Vgontzas et al (2002)118 Patients with chronic insomnia showed a significant shift of IL-6 and TNF-! secretion from nighttime to daytime Vgontzas et al (1997)119 The levels of daytime IL-6 and TNF-! were elevated in the patients with sleep disturbance compared with those in the normal…”
BackgroundBuckley, T. M., & Schatzberg, A. F. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1056 · Cited by 964 · cited 3×
“…patients with sleep disturbance compared with those in the normal control HPA axis dysregulation Born et al (1986)120; Follenius et al (1992)121; Buckley and Schatzberg (2005)122 The pattern of nocturnal secretion of cortisol was associated with nocturnal sleep-wake pattern and sleep…”
BackgroundInfluentialBrain-immune communication pathways
Quan, N., & Banks, W. A. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.05.005 · Cited by 626
Estrogen and cognitive functioning in women
Sherwin, B. B. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0016 · Cited by 560 · cited 1×
“Estrogen is involved in various psychoneurological symptoms including mood, locomotor activity, pain sensitivity, and cognition.(244,245) Also, hot flashes in breast cancer patients are an ultimate product of estrogen withdrawal, and changes in 5-HT are thought to be involved in its final pathological mechanism.”
BackgroundCapuron, L., Ravaud, A., Neveu, P. J., Miller, A. H., Maes, M., & Dantzer, R. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4000995 · Cited by 473 · cited 3×
“…symptoms Alesci et al (2005)44; Dinan et al (2009)45 Patients with depression showed elevated cytokine levels and shift of their circadian rhythms Capuron et al (2002)46; Yirmiya et al (2001)47 Antidepressants had anti-inflammatory properties and reversed cytokine-induced depressive symptoms…”
BackgroundTuglu, C., Kara, S. H., Caliyurt, O., Vardar, E., & Abay, E. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1566-z · Cited by 391
Effects of Cytokines on Cerebral Neurotransmission: Comparison with the Effects of Stress
Dunn, A. J., Wang, J., & Ando, T. (1999) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-585-37970-8_8 · Cited by 316
The Neuroendocrinology of Chronic Fatigue Syndrome
Cleare, A. J. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0014 · Cited by 315 · cited 1×
“…hypothalamic 5-HT; dopamine ratio was negatively associated with time to fatigue after exercise in angiotensin-inhibited rats HPA axis dysregulation Cleare (2003)95 Patients with chronic fatigue syndrome showed the enhanced negative feedback in HPA axis and glucocorticoid receptor function and…”
BackgroundCapuron, L., Raison, C. L., Musselman, D. L., Lawson, D. H., Nemeroff, C. B., & Miller, A. H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.7.1342 · Cited by 308 · cited 1×
“However, neurovegetative symptoms (eg, fatigue, anorexia, pain) were not associated with these biological markers.(207,208) These findings suggest that proinflammatory cytokines may only be an initiating factor in a sequential process (or cascade) that generates the psychoneurological symptom cluster.”
BackgroundSparkman, N. L., Buchanan, J. B., Heyen, J. R. R., Chen, J., Beverly, J. L., & Johnson, R. W. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3376-06.2006 · Cited by 307 · cited 1×
“High scores were found in cognitive function test during menstrual phase and low scores during midluteal phase Proinflammatory cytokines Sparkman et al (2006)73 Mice that received cytokine-producing substances exhibited deficit in working memory, whereas IL-6 knockout mice did not Capuron et al…”
BackgroundLambert, G., Johansson, M., Ågren, H., & Friberg, P. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.8.787 · Cited by 303
Anxiety and depression in patients with rheumatoid arthritis
Isik, A., Koca, S. S., Ozturk, A., & Mermi, O. (2007) · Clinical Rheumatology · doi:10.1007/s10067-006-0407-y · Cited by 276
Interleukin-1 mediates the behavioral hyperalgesia produced by lithium chloride and endotoxin
Maier, S. F., Wiertelak, E. P., Martin, D., & Watkins, L. R. (1993) · Brain Research · doi:10.1016/0006-8993(93)91446-y · Cited by 210
Symptom Clusters in Breast Cancer Across 3 Phases of the Disease
Bender, C. M., Erg??n, F. S., Rosenzweig, M. Q., Cohen, S. M., & Sereika, S. M. (2005) · Cancer Nursing · doi:10.1097/00002820-200505000-00011 · Cited by 194
Nocturnal Cortisol Release in Relation to Sleep Structure
Follenius, M., Brandenberger, G., Bandesapt, J. J., Libert, J. P., & Ehrhart, J. (1992) · Sleep · doi:10.1093/sleep/15.1.21 · Cited by 185
Raison, C. L., Borisov, A. S., Woolwine, B. J., Massung, B., Vogt, G., & Miller, A. H. (2010) · Molecular Psychiatry · doi:10.1038/mp.2008.58 · Cited by 183
Lestage, J., Verrier, D., Palin, K., & Dantzer, R. (2002) · Brain, Behavior, and Immunity · doi:10.1016/s0889-1591(02)00014-4 · Cited by 170
The contribution of the vagus nerve in interleukin-1β-induced fever is dependent on dose
Hansen, M. K., O'Connor, K. A., Goehler, L. E., Watkins, L. R., & Maier, S. F. (2001) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2001.280.4.r929 · Cited by 169
Symptom clusters in patients with advanced cancers
Cheung, W. Y., Le, L. W., & Zimmermann, C. (2009) · Supportive Care in Cancer · doi:10.1007/s00520-009-0577-7 · Cited by 166
Symptom clusters in cancer patients
Chen, M.-L., & Tseng, H.-C. (2006) · Supportive Care in Cancer · doi:10.1007/s00520-006-0019-8 · Cited by 159 · cited 1×
“…commonly formed a cluster across 3 different samples (ie, fatigue related symptoms, cognitive impairmentYrelated symptoms, and mood problems) Chen and Tseng (2006)15 N = 151 all types of cancer Factor analysis Three symptom clusters were found (1) Sickness symptom cluster (ie,…”
BackgroundCapuron, L., Ravaud, A., & Dantzer, R. (2001) · Psychosomatic Medicine · doi:10.1097/00006842-200105000-00007 · Cited by 148 · cited 3×
“Cytokines can induce neurological damage in specific regions of the brain (eg, frontal lobe) and/or alterations in neurotransmitter function.(74,86) Anemia can induce cognitive disturbance through hypoxic damage to the brain.”
BackgroundCastanon, N., Bluthé, R.-M., & Dantzer, R. (2001) · Psychopharmacology · doi:10.1007/s002130000595 · Cited by 136
Merali, Z., Brennan, K., Brau, P., & Anisman, H. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1273-1 · Cited by 127
Cited by
So, W. K. W., Law, B. M. H., Ng, M. S. N., He, X., Chan, D. N. S., Chan, C. W. H., & McCarthy, A. L. (2021) · Cancer Medicine · doi:10.1002/cam4.3794 · Cited by 181
Telephone interventions for symptom management in adults with cancer
Ream, E., Hughes, A. E., Cox, A., Skarparis, K., Richardson, A., Pedersen, V. H., Wiseman, T., Forbes, A., & Bryant, A. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007568.pub2 · Cited by 113
“People with cancer oKen experience a variety of symptoms as a result of their disease and its treatment (Harrington 2010; Kim 2012; Van Lancker 2014).”
BackgroundSymptom Burden of Adults with Type 2 Diabetes Across the Disease Course: Diabetes & Aging Study
Sudore, R. L., Karter, A. J., Huang, E. S., Moffet, H. H., Laiteerapong, N., Schenker, Y., Adams, A., Whitmer, R. A., Liu, J. Y., Miao, Y., et al. (2012) · Journal of General Internal Medicine · doi:10.1007/s11606-012-2132-3 · Cited by 105
Franco, S., Olfson, M., Wall, M. M., Wang, S., Hoertel, N., & Blanco, C. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.03.003 · Cited by 82
Circadian disruption and cancer- and treatment-related symptoms
Amidi, A., & Wu, L. M. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1009064 · Cited by 59
Metadata
- Authors
- Kim, H.-J., Barsevick, A. M., Fang, C. Y., & Miaskowski, C.
- Venue
- Cancer Nursing
- Published
- 2012-11
- Volume
- 35
- Issue
- 6
- Pages
- E1-E20
- ISSN
- 0162-220X (ISSN-L)
- OpenAlex
- W2089273506
- Cited by
- 181
- References
- 29
- FWCI
- 4.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.